Skip to main content

Real Smart Drugs and Treatment

  • Chapter
  • First Online:
  • 588 Accesses

Abstract

Feeling Smarter and Smarter has thus far highlighted the dramatic improvements possible when dyslexics are properly understood, diagnosed, and medically treated. These improvements, typical of many thousands, have been presented to you through the personal accounts volunteered by my many patients and/or their loved ones.

This is a preview of subscription content, log in via an institution.

Buying options

eBook
USD   19.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   24.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    Some chemical substances may have overlapping Group I and Group II functioning.

  2. 2.

    Clearly, placebos invariably play a role in med and other therapies. And as you will have by now seen, any role they play must involve the CVS as must non-placebo responses—since they superficially trigger similar outcomes. And the overall favorable response factor in placebo effects appears to vary significantly with the meds and their chemical/therapeutic categories. Although I have come to clinically recognize this role to be minimal in cases not anticipating favorable responses, only future double-blind studies using a method I have devised will clarify this issue.

  3. 3.

    No doubt, readers will now better understand my prior footnotes in both this and Chap. 5, critiquing a triple-blind study using only one dose of one drug for all dyslexic subjects and attempting to draw reliable conclusions based only on reading score performance after three months of meclizine treatment. Although the researcher, Fagan, was told all about the above drawbacks and advised as to the study’s best design, he chose to proceed as he initially thought best. As a psychoanalyst, I can only wonder why he came to seek my advice. And why he chose to ignore it.

  4. 4.

    Percept Mot Skills, 73, 723–38. Levinson, H. N. (1991). pg 736. This study design was offered Fagan, although he declined—no doubt favoring one he initially thought best, despite a complete absence of understanding dyslexia or of the complex intricacies involved in my medical treatment. These many and diverse unanticipated insights occurred slowly over many decades. Thus, his results were doomed to be misleading at best. And they were.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Levinson, H.N. (2019). Real Smart Drugs and Treatment. In: Feeling Smarter and Smarter. Copernicus, Cham. https://doi.org/10.1007/978-3-030-16208-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16208-5_21

  • Published:

  • Publisher Name: Copernicus, Cham

  • Print ISBN: 978-3-030-16207-8

  • Online ISBN: 978-3-030-16208-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics